Your browser doesn't support javascript.
loading
Targeted therapies for HPV-associated cervical cancer: Harnessing the potential of exosome-based chipsets in combating leukemia and HPV-mediated cervical cancer.
Maitra, Swastika; Mukerjee, Nobendu; Alharbi, Hanan M; Ghosh, Arabinda; Alexiou, Athanasios; Thorat, Nanasaheb D.
Afiliación
  • Maitra S; Department of Microbiology, Adamas University, Kolkata, India.
  • Mukerjee N; Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, India.
  • Alharbi HM; Department of Health Sciences, Novel Global Community Educational Foundation, Hebersham, New South Wales, Australia.
  • Ghosh A; Department of Pharmaceutical Sciences, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Alexiou A; Department of Molecular Biology and Bioinformatics, Tripura University (A Central University), Suryamaninagar, Tripura, India.
  • Thorat ND; Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, New South Wales, Australia.
J Med Virol ; 96(4): e29596, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38590017
ABSTRACT
Exosomes play a crucial role in intercellular communication and have emerged as significant vehicles for transporting disease-specific biomarkers. This feature provides profound insights into the progression of diseases and the responses of patients to treatments. For example, in leukemia, exosomes convey critical information through the carriage of specific proteins and nucleic acids. In the case of human papillomavirus (HPV)-mediated cervical cancer, exosomes are particularly useful for noninvasive detection as they transport high-risk HPV DNA and specific biomolecules, which can be indicators of the disease. Despite their vast potential, there are several challenges associated with the use of exosomes in medical diagnostics. These include their inherent heterogeneity, the need for enhanced sensitivity in detection methods, the establishment of standardization protocols, and the requirement for cost-effective scalability in their application. Addressing these challenges is crucial for the effective implementation of exosome-based diagnostics. Future research and development are geared towards overcoming these obstacles. Efforts are concentrated on refining the processes of biomarker discovery, establishing comprehensive regulatory frameworks, developing convenient point-of-care devices, exploring methods for multimodal detection, and conducting extensive clinical trials. The ultimate goal of these efforts is to inaugurate a new era of precision diagnostics within healthcare. This would significantly improve patient outcomes and reduce the burden of diseases such as leukemia and HPV-mediated cervical cancer. The integration of exosomes with cutting-edge technology holds the promise of significantly reinforcing the foundations of healthcare, leading to enhanced diagnostic accuracy, better disease monitoring, and more personalized therapeutic approaches.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia / Neoplasias del Cuello Uterino / Infecciones por Papillomavirus / Exosomas Límite: Female / Humans Idioma: En Revista: J Med Virol / J. med. virol / Journal of medical virology Año: 2024 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia / Neoplasias del Cuello Uterino / Infecciones por Papillomavirus / Exosomas Límite: Female / Humans Idioma: En Revista: J Med Virol / J. med. virol / Journal of medical virology Año: 2024 Tipo del documento: Article País de afiliación: India